ArticleOncoTargets and therapy2019

VE-822 mediated inhibition of ATR signaling sensitizes chondrosarcoma to cisplatin via reversion of the DNA damage response.

Xiao Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.